Log in to save to my catalogue

Intravenous immunoglobulin treatment in childhood encephalitis (IgNiTE): a randomised controlled tri...

Intravenous immunoglobulin treatment in childhood encephalitis (IgNiTE): a randomised controlled tri...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d95df2e0dc6244059c752071a77d38ed

Intravenous immunoglobulin treatment in childhood encephalitis (IgNiTE): a randomised controlled trial

About this item

Full title

Intravenous immunoglobulin treatment in childhood encephalitis (IgNiTE): a randomised controlled trial

Publisher

London: British Medical Journal Publishing Group

Journal title

BMJ open, 2023-11, Vol.13 (11), p.e072134-e072134

Language

English

Formats

Publication information

Publisher

London: British Medical Journal Publishing Group

More information

Scope and Contents

Contents

ObjectiveTo investigate whether intravenous immunoglobulin (IVIG) improves neurological outcomes in children with encephalitis when administered early in the illness.DesignPhase 3b multicentre, double-blind, randomised placebo-controlled trial.SettingTwenty-one hospitals in the UK.ParticipantsChildren aged 6 months to 16 years with a diagnosis of a...

Alternative Titles

Full title

Intravenous immunoglobulin treatment in childhood encephalitis (IgNiTE): a randomised controlled trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d95df2e0dc6244059c752071a77d38ed

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d95df2e0dc6244059c752071a77d38ed

Other Identifiers

ISSN

2044-6055

E-ISSN

2044-6055

DOI

10.1136/bmjopen-2023-072134

How to access this item